CML-CAB Objectives & Strategy

The CML-CAB objectives are:

• Providing researchers, academics, government, policy makers, authorities and the pharmaceutical industry with advice and input on different issues that impact on patients’ lives
• Promoting best-in-class CML research as well as the harmonisation of good clinical practice, standard of care and access to best available CML therapies and diagnostic tools
• Ensuring patient needs are considered when setting research priorities
• Developing patient-friendly clinical trials and helping interested patients access these
• Addressing problems CML patients face in accessing optimal diagnosis, monitoring, treatment and care
• Improving the outcomes of CML patients
• Improving the quality of patient information and education
• Building CML advocacy community capacity

Strategic priorities

To learn more about CML Community Advisory Boards, watch our CML-CAB video.